ArticleThe Prostate2020

Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth.

Gregory Carbonetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.